AYBARION TRADEEU trade movers · 2026-01 · chapter 30
EU trade movers: January 2026, Pharmaceutical products
The largest month on month and year on year changes in the trade of each EU member state with each partner country, per HS4 product in chapter 30. Flows of at least EUR 5 million in January 2026; percent lists need at least EUR 1 million in the comparison month. Every figure carries its Eurostat record ID.
December 2025 · February 2026 · All chapters, January 2026 · Atom feed
Largest month on month changes, EUR
| # | Flow | Product | January 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Slovenia exports to Switzerland | 3004 Medicaments | EUR 831.2 million | EUR 2.1 billion 2025-12 | −EUR 1.3 billion | −60.2% | DS-045409:SI:CH:3004:2:2026-01 DS-045409:SI:CH:3004:2:2025-12 |
| 2 | Belgium imports from Ireland | 3003 Medicaments | EUR 194.3 million | EUR 1.4 billion 2025-12 | −EUR 1.2 billion | −85.8% | DS-045409:BE:IE:3003:1:2026-01 DS-045409:BE:IE:3003:1:2025-12 |
| 3 | Germany exports to United States | 3002 Human blood | EUR 2.2 billion | EUR 1.1 billion 2025-12 | +EUR 1.1 billion | +95.9% | DS-045409:DE:US:3002:2:2026-01 DS-045409:DE:US:3002:2:2025-12 |
| 4 | Ireland exports to Belgium | 3003 Medicaments | EUR 181.3 million | EUR 1.2 billion 2025-12 | −EUR 1.0 billion | −84.8% | DS-045409:IE:BE:3003:2:2026-01 DS-045409:IE:BE:3003:2:2025-12 |
| 5 | Italy exports to United States | 3004 Medicaments | EUR 1.2 billion | EUR 525.6 million 2025-12 | +EUR 639.9 million | +121.7% | DS-045409:IT:US:3004:2:2026-01 DS-045409:IT:US:3004:2:2025-12 |
| 6 | Belgium exports to Germany | 3004 Medicaments | EUR 588.8 million | EUR 165.3 million 2025-12 | +EUR 423.5 million | +256.1% | DS-045409:BE:DE:3004:2:2026-01 DS-045409:BE:DE:3004:2:2025-12 |
| 7 | Germany imports from Belgium | 3004 Medicaments | EUR 566.4 million | EUR 172.3 million 2025-12 | +EUR 394.1 million | +228.8% | DS-045409:DE:BE:3004:1:2026-01 DS-045409:DE:BE:3004:1:2025-12 |
| 8 | Germany exports to Switzerland | 3004 Medicaments | EUR 237.2 million | EUR 629.9 million 2025-12 | −EUR 392.6 million | −62.3% | DS-045409:DE:CH:3004:2:2026-01 DS-045409:DE:CH:3004:2:2025-12 |
| 9 | Italy exports to Ireland | 3004 Medicaments | EUR 564.9 million | EUR 223.1 million 2025-12 | +EUR 341.8 million | +153.2% | DS-045409:IT:IE:3004:2:2026-01 DS-045409:IT:IE:3004:2:2025-12 |
| 10 | Netherlands exports to Germany | 3002 Human blood | EUR 558.5 million | EUR 219.1 million 2025-12 | +EUR 339.4 million | +154.9% | DS-045409:NL:DE:3002:2:2026-01 DS-045409:NL:DE:3002:2:2025-12 |
| 11 | Belgium imports from Italy | 3004 Medicaments | EUR 633.0 million | EUR 339.5 million 2025-12 | +EUR 293.5 million | +86.4% | DS-045409:BE:IT:3004:1:2026-01 DS-045409:BE:IT:3004:1:2025-12 |
| 12 | Belgium exports to Italy | 3004 Medicaments | EUR 266.2 million | EUR 556.5 million 2025-12 | −EUR 290.3 million | −52.2% | DS-045409:BE:IT:3004:2:2026-01 DS-045409:BE:IT:3004:2:2025-12 |
| 13 | Belgium imports from United States | 3004 Medicaments | EUR 437.8 million | EUR 719.2 million 2025-12 | −EUR 281.4 million | −39.1% | DS-045409:BE:US:3004:1:2026-01 DS-045409:BE:US:3004:1:2025-12 |
| 14 | Italy exports to Belgium | 3004 Medicaments | EUR 575.0 million | EUR 301.6 million 2025-12 | +EUR 273.4 million | +90.6% | DS-045409:IT:BE:3004:2:2026-01 DS-045409:IT:BE:3004:2:2025-12 |
| 15 | Germany imports from Switzerland | 3004 Medicaments | EUR 332.9 million | EUR 92.2 million 2025-12 | +EUR 240.7 million | +261.2% | DS-045409:DE:CH:3004:1:2026-01 DS-045409:DE:CH:3004:1:2025-12 |
Largest month on month changes, percent
| # | Flow | Product | January 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland exports to Japan | 3002 Human blood | EUR 209.0 million | EUR 6.0 million 2025-12 | +EUR 203.0 million | +3,360.5% | DS-045409:IE:JP:3002:2:2026-01 DS-045409:IE:JP:3002:2:2025-12 |
| 2 | Denmark exports to Czechia | 3004 Medicaments | EUR 23.4 million | EUR 1.2 million 2025-12 | +EUR 22.2 million | +1,904.9% | DS-045409:DK:CZ:3004:2:2026-01 DS-045409:DK:CZ:3004:2:2025-12 |
| 3 | Ireland imports from Germany | 3003 Medicaments | EUR 174.9 million | EUR 9.9 million 2025-12 | +EUR 165.0 million | +1,667.0% | DS-045409:IE:DE:3003:1:2026-01 DS-045409:IE:DE:3003:1:2025-12 |
| 4 | Italy imports from Japan | 3004 Medicaments | EUR 36.5 million | EUR 2.2 million 2025-12 | +EUR 34.2 million | +1,522.2% | DS-045409:IT:JP:3004:1:2026-01 DS-045409:IT:JP:3004:1:2025-12 |
| 5 | France exports to Japan | 3002 Human blood | EUR 17.8 million | EUR 1.1 million 2025-12 | +EUR 16.7 million | +1,460.2% | DS-045409:FR:JP:3002:2:2026-01 DS-045409:FR:JP:3002:2:2025-12 |
| 6 | Denmark exports to Sweden | 3004 Medicaments | EUR 70.5 million | EUR 4.8 million 2025-12 | +EUR 65.7 million | +1,362.8% | DS-045409:DK:SE:3004:2:2026-01 DS-045409:DK:SE:3004:2:2025-12 |
| 7 | Germany imports from South Korea | 3002 Human blood | EUR 24.2 million | EUR 1.9 million 2025-12 | +EUR 22.3 million | +1,172.6% | DS-045409:DE:KR:3002:1:2026-01 DS-045409:DE:KR:3002:1:2025-12 |
| 8 | Sweden exports to Norway | 3004 Medicaments | EUR 34.3 million | EUR 2.8 million 2025-12 | +EUR 31.6 million | +1,137.4% | DS-045409:SE:NO:3004:2:2026-01 DS-045409:SE:NO:3004:2:2025-12 |
| 9 | Netherlands imports from Canada | 3002 Human blood | EUR 10.8 million | EUR 1.0 million 2025-12 | +EUR 9.8 million | +959.7% | DS-045409:NL:CA:3002:1:2026-01 DS-045409:NL:CA:3002:1:2025-12 |
| 10 | Spain exports to South Africa | 3004 Medicaments | EUR 48.7 million | EUR 4.9 million 2025-12 | +EUR 43.8 million | +894.3% | DS-045409:ES:ZA:3004:2:2026-01 DS-045409:ES:ZA:3004:2:2025-12 |
| 11 | Sweden exports to Russia | 3004 Medicaments | EUR 52.5 million | EUR 5.3 million 2025-12 | +EUR 47.2 million | +893.6% | DS-045409:SE:RU:3004:2:2026-01 DS-045409:SE:RU:3004:2:2025-12 |
| 12 | Ireland exports to Mexico | 3002 Human blood | EUR 24.2 million | EUR 2.5 million 2025-12 | +EUR 21.7 million | +877.8% | DS-045409:IE:MX:3002:2:2026-01 DS-045409:IE:MX:3002:2:2025-12 |
| 13 | Netherlands exports to Hungary | 3002 Human blood | EUR 86.8 million | EUR 8.9 million 2025-12 | +EUR 77.9 million | +874.5% | DS-045409:NL:HU:3002:2:2026-01 DS-045409:NL:HU:3002:2:2025-12 |
| 14 | Sweden imports from Switzerland | 3004 Medicaments | EUR 12.7 million | EUR 1.3 million 2025-12 | +EUR 11.4 million | +869.0% | DS-045409:SE:CH:3004:1:2026-01 DS-045409:SE:CH:3004:1:2025-12 |
| 15 | Ireland exports to Saudi Arabia | 3004 Medicaments | EUR 66.5 million | EUR 6.9 million 2025-12 | +EUR 59.5 million | +857.2% | DS-045409:IE:SA:3004:2:2026-01 DS-045409:IE:SA:3004:2:2025-12 |
Largest year on year changes, EUR
| # | Flow | Product | January 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Germany exports to United States | 3002 Human blood | EUR 2.2 billion | EUR 1.0 billion 2025-01 | +EUR 1.2 billion | +113.5% | DS-045409:DE:US:3002:2:2026-01 DS-045409:DE:US:3002:2:2025-01 |
| 2 | Slovenia exports to Switzerland | 3004 Medicaments | EUR 831.2 million | EUR 1.9 billion 2025-01 | −EUR 1.1 billion | −56.4% | DS-045409:SI:CH:3004:2:2026-01 DS-045409:SI:CH:3004:2:2025-01 |
| 3 | Belgium imports from Ireland | 3003 Medicaments | EUR 194.3 million | EUR 919.7 million 2025-01 | −EUR 725.5 million | −78.9% | DS-045409:BE:IE:3003:1:2026-01 DS-045409:BE:IE:3003:1:2025-01 |
| 4 | Ireland exports to Belgium | 3003 Medicaments | EUR 181.3 million | EUR 851.2 million 2025-01 | −EUR 669.9 million | −78.7% | DS-045409:IE:BE:3003:2:2026-01 DS-045409:IE:BE:3003:2:2025-01 |
| 5 | Italy exports to United States | 3004 Medicaments | EUR 1.2 billion | EUR 547.8 million 2025-01 | +EUR 617.7 million | +112.8% | DS-045409:IT:US:3004:2:2026-01 DS-045409:IT:US:3004:2:2025-01 |
| 6 | Germany imports from Ireland | 3004 Medicaments | EUR 265.3 million | EUR 779.4 million 2025-01 | −EUR 514.1 million | −66.0% | DS-045409:DE:IE:3004:1:2026-01 DS-045409:DE:IE:3004:1:2025-01 |
| 7 | Italy exports to Ireland | 3004 Medicaments | EUR 564.9 million | EUR 59.0 million 2025-01 | +EUR 505.9 million | +857.8% | DS-045409:IT:IE:3004:2:2026-01 DS-045409:IT:IE:3004:2:2025-01 |
| 8 | Ireland imports from United States | 3002 Human blood | EUR 271.6 million | EUR 705.4 million 2025-01 | −EUR 433.8 million | −61.5% | DS-045409:IE:US:3002:1:2026-01 DS-045409:IE:US:3002:1:2025-01 |
| 9 | Ireland exports to Germany | 3004 Medicaments | EUR 298.2 million | EUR 723.3 million 2025-01 | −EUR 425.1 million | −58.8% | DS-045409:IE:DE:3004:2:2026-01 DS-045409:IE:DE:3004:2:2025-01 |
| 10 | Netherlands exports to United States | 3004 Medicaments | EUR 104.5 million | EUR 517.5 million 2025-01 | −EUR 413.0 million | −79.8% | DS-045409:NL:US:3004:2:2026-01 DS-045409:NL:US:3004:2:2025-01 |
| 11 | Ireland imports from Italy | 3004 Medicaments | EUR 398.3 million | EUR 10.2 million 2025-01 | +EUR 388.1 million | +3,821.0% | DS-045409:IE:IT:3004:1:2026-01 DS-045409:IE:IT:3004:1:2025-01 |
| 12 | Belgium exports to United States | 3004 Medicaments | EUR 458.4 million | EUR 829.5 million 2025-01 | −EUR 371.1 million | −44.7% | DS-045409:BE:US:3004:2:2026-01 DS-045409:BE:US:3004:2:2025-01 |
| 13 | Austria exports to United States | 3002 Human blood | EUR 58.3 million | EUR 366.7 million 2025-01 | −EUR 308.4 million | −84.1% | DS-045409:AT:US:3002:2:2026-01 DS-045409:AT:US:3002:2:2025-01 |
| 14 | Belgium imports from Ireland | 3002 Human blood | EUR 317.3 million | EUR 603.6 million 2025-01 | −EUR 286.2 million | −47.4% | DS-045409:BE:IE:3002:1:2026-01 DS-045409:BE:IE:3002:1:2025-01 |
| 15 | Germany imports from Belgium | 3004 Medicaments | EUR 566.4 million | EUR 284.3 million 2025-01 | +EUR 282.1 million | +99.2% | DS-045409:DE:BE:3004:1:2026-01 DS-045409:DE:BE:3004:1:2025-01 |
Largest year on year changes, percent
| # | Flow | Product | January 2026 | Comparison | Change | Change % | Records |
|---|---|---|---|---|---|---|---|
| 1 | Ireland imports from Italy | 3004 Medicaments | EUR 398.3 million | EUR 10.2 million 2025-01 | +EUR 388.1 million | +3,821.0% | DS-045409:IE:IT:3004:1:2026-01 DS-045409:IE:IT:3004:1:2025-01 |
| 2 | Italy exports to India | 3004 Medicaments | EUR 46.2 million | EUR 1.7 million 2025-01 | +EUR 44.5 million | +2,546.5% | DS-045409:IT:IN:3004:2:2026-01 DS-045409:IT:IN:3004:2:2025-01 |
| 3 | Denmark exports to Sweden | 3004 Medicaments | EUR 70.5 million | EUR 2.9 million 2025-01 | +EUR 67.6 million | +2,322.0% | DS-045409:DK:SE:3004:2:2026-01 DS-045409:DK:SE:3004:2:2025-01 |
| 4 | Italy exports to Taiwan | 3004 Medicaments | EUR 70.9 million | EUR 4.4 million 2025-01 | +EUR 66.5 million | +1,510.1% | DS-045409:IT:TW:3004:2:2026-01 DS-045409:IT:TW:3004:2:2025-01 |
| 5 | Denmark exports to Finland | 3004 Medicaments | EUR 22.0 million | EUR 1.4 million 2025-01 | +EUR 20.6 million | +1,497.9% | DS-045409:DK:FI:3004:2:2026-01 DS-045409:DK:FI:3004:2:2025-01 |
| 6 | Slovenia imports from Denmark | 3004 Medicaments | EUR 23.1 million | EUR 1.6 million 2025-01 | +EUR 21.5 million | +1,350.5% | DS-045409:SI:DK:3004:1:2026-01 DS-045409:SI:DK:3004:1:2025-01 |
| 7 | Germany exports to Switzerland | 3003 Medicaments | EUR 20.4 million | EUR 1.5 million 2025-01 | +EUR 18.9 million | +1,272.1% | DS-045409:DE:CH:3003:2:2026-01 DS-045409:DE:CH:3003:2:2025-01 |
| 8 | Italy exports to Japan | 3002 Human blood | EUR 37.0 million | EUR 2.9 million 2025-01 | +EUR 34.1 million | +1,163.1% | DS-045409:IT:JP:3002:2:2026-01 DS-045409:IT:JP:3002:2:2025-01 |
| 9 | Italy exports to Kuwait | 3004 Medicaments | EUR 13.4 million | EUR 1.1 million 2025-01 | +EUR 12.3 million | +1,120.8% | DS-045409:IT:KW:3004:2:2026-01 DS-045409:IT:KW:3004:2:2025-01 |
| 10 | France exports to Mexico | 3002 Human blood | EUR 29.9 million | EUR 2.6 million 2025-01 | +EUR 27.3 million | +1,040.2% | DS-045409:FR:MX:3002:2:2026-01 DS-045409:FR:MX:3002:2:2025-01 |
| 11 | Ireland exports to United States | 3003 Medicaments | EUR 21.2 million | EUR 2.0 million 2025-01 | +EUR 19.2 million | +978.0% | DS-045409:IE:US:3003:2:2026-01 DS-045409:IE:US:3003:2:2025-01 |
| 12 | Spain exports to South Africa | 3004 Medicaments | EUR 48.7 million | EUR 4.6 million 2025-01 | +EUR 44.2 million | +964.4% | DS-045409:ES:ZA:3004:2:2026-01 DS-045409:ES:ZA:3004:2:2025-01 |
| 13 | Spain exports to Australia | 3004 Medicaments | EUR 46.4 million | EUR 4.8 million 2025-01 | +EUR 41.6 million | +868.5% | DS-045409:ES:AU:3004:2:2026-01 DS-045409:ES:AU:3004:2:2025-01 |
| 14 | Italy exports to Ireland | 3004 Medicaments | EUR 564.9 million | EUR 59.0 million 2025-01 | +EUR 505.9 million | +857.8% | DS-045409:IT:IE:3004:2:2026-01 DS-045409:IT:IE:3004:2:2025-01 |
| 15 | Ireland exports to Mexico | 3002 Human blood | EUR 24.2 million | EUR 2.6 million 2025-01 | +EUR 21.6 million | +847.2% | DS-045409:IE:MX:3002:2:2026-01 DS-045409:IE:MX:3002:2:2025-01 |
Data Passport
- Eurostat Comext DS-045409: monthly trade of the EU member states by partner country and product, EUR and net mass, months 2025-12, 2026-01 and 2025-01. Licence: Eurostat reuse policy, free reuse with attribution "Source: Eurostat" (© European Union). Record IDs: DS-045409:reporter:partner:product:flow:month. Source
- Method: For each EU reporter, HS4 product, partner country and flow, the value of January 2026 is compared with the month before and with the same month a year earlier. A missing month row counts as no recorded trade. Lists rank by the absolute change in EUR or by the percent change; aggregates (world, intra and extra EU) and confidential partners are left out, as are Peru and the Philippines.
Trade database built 2026-10-24. Values are official statistics as published; nothing on this page is estimated or invented. More in our methodology.
See the companies
Members see the importers and exporters behind these flows, with their evidence and Data Passport.